Login / Signup

Efficacy and safety of SBRT combined with sintilimab and IBI305 in patients with advanced HCC and previously failed immunotherapy: study protocol of a phase 2 clinical trial.

Jinfeng ZhangYongqiang YangZilong WuSisi ZhangZhenyu LinHongli LiuJianli HuTao ZhangJing TangJun Xue
Published in: BMJ open (2024)
ChiCTR2200056068.
Keyphrases
  • clinical trial
  • study protocol
  • radiation therapy
  • randomized controlled trial
  • open label
  • double blind
  • phase ii
  • phase iii
  • placebo controlled